Your browser doesn't support javascript.
loading
An Open-Label, Randomized, Multi-Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin-2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma.
Hasanov, Merve; Milton, Denái R; Sharfman, William H; Taback, Bret; Cranmer, Lee D; Daniels, Gregory A; Flaherty, Lawrence; Hallmeyer, Sigrun; Milhem, Mohammed; Feun, Lynn; Hauke, Ralph; Doolittle, Gary; Gregory, Nancy; Patel, Sapna.
Affiliation
  • Hasanov M; Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas Md Anderson Cancer Center, Houston, USA.
  • Milton DR; Department of Biostatistics, The University of Texas Md Anderson Cancer Center, Houston, USA.
  • Sharfman WH; Department of Medical Oncology and Dermatology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Lutherville, USA.
  • Taback B; Department of Surgery, Division of Breast Surgery, New York-Presbyterian/Columbia University Medical Center, New York, USA.
  • Cranmer LD; University of Arizona Cancer Center, Tucson, Az, Usa. Present Affiliation and Contact: Division of Medical Oncology, Department of Medicine, University of Washington Medical Center, and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, USA.
  • Daniels GA; Division of Hematology-Oncology, University of California San Diego, La Jolla, USA.
  • Flaherty L; Department of Hematology-Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, USA.
  • Hallmeyer S; Department of Hematology-Oncology, Advocate Medical Group, Park Ridge, USA.
  • Milhem M; Section of Oncology, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, USA.
  • Feun L; Department of Medical Oncology, University of Miami Health System, Miami, USA.
  • Hauke R; Nebraska Cancer Specialists, Omaha, USA.
  • Doolittle G; Division of Medical Oncology, Department of Medicine, University of Kansas Medical Center, Kansas City, USA.
  • Gregory N; Clinigen Group, Yardley, USA.
  • Patel S; Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas Md Anderson Cancer Center, Houston, USA.
Oncoimmunology ; 10(1): 1984059, 2021.
Article in En | MEDLINE | ID: mdl-34650833
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Interleukin-2 / Melanoma Type of study: Clinical_trials Limits: Humans Language: En Journal: Oncoimmunology Year: 2021 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Interleukin-2 / Melanoma Type of study: Clinical_trials Limits: Humans Language: En Journal: Oncoimmunology Year: 2021 Type: Article Affiliation country: United States